id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-D-0589-0030,FDA,FDA-2010-D-0589,Attachment 4 ICU I Hospital-Acquired Bacterial Pneumonia (HABP) and VentilatorAssociated Bacterial Pneumonia (VABP) re: Comment from Foundation for the National Institutes of Health,Supporting & Related Material,Background Material,2017-06-05T04:00:00Z,2017,6,,,2017-06-05T18:16:22Z,,0,0,0900006482690b8d
FDA-2010-D-0589-0031,FDA,FDA-2010-D-0589,Attachment 5 Statistical Tables and Data re: Comment from Foundation for the National Institutes of Health,Supporting & Related Material,Background Material,2017-06-05T04:00:00Z,2017,6,,,2017-06-05T18:23:37Z,,0,0,0900006482690b8e
FDA-2010-D-0589-0028,FDA,FDA-2010-D-0589,Attachment 1 Statistical Analysis Plan Biomarkers Consortium of the Foundation for the National Institutes of Health HABP/NABP Working Group Part 2 Analysis Version 6.0 re: Comment from Foundation for the National Institutes of Health,Supporting & Related Material,Background Material,2017-06-05T04:00:00Z,2017,6,,,2017-06-05T18:09:30Z,,0,0,0900006482690d5a
FDA-2010-D-0589-0032,FDA,FDA-2010-D-0589,Attachment 6 Statistical Tables and Data re: Comment from Foundation for the National Institutes of Health,Supporting & Related Material,Background Material,2017-06-05T04:00:00Z,2017,6,,,2017-06-05T18:33:11Z,,0,0,0900006482690b8f
FDA-2010-D-0589-0029,FDA,FDA-2010-D-0589,"Attachment 2 Theravance Biopharma Medicines that make a difference® ATTAIN Studies Overview May 15, 2015 re: Comment from Foundation for the National Institutes of Health",Supporting & Related Material,Background Material,2017-06-05T04:00:00Z,2017,6,,,2017-06-05T18:11:25Z,,0,0,0900006482690d5b